Next-Generation Sequencing in Latin America
|出版日期||內容資訊||英文 30 Pages
This report, ‘Next Generation Sequencing in Latin America’, is a look at the use of DNA sequencing systems in the region, based on Survey conducted by VA Consultadoros in Fall 2013. The survey focused on instrumentation, with a goal of providing a complete count of NGS systems sold to customers in key Latin American Countries.
Latin America is a focus for healthcare markets. During 2000-2010 the region went through its highest economic growth period in the last four decades. Economics brought almost a third of the total population in the region into the
middle class status-with around 70 percent of them living in Brazil, Mexico and Argentina. The economic development has translated into investment in these nation's healthcare systems, which in terms has increased the focus on high-end biotechnology instrument spending for clinical research and diagnostics.
Genomics studies product cycle with Next Generation Sequencing (NGS) technology in Latin America (LatAm) is in its exponential phase and market growth is larger than the regional investment in Science and Technology (S&T) compared against the expenditure in S&T as a percentage of GDP. Because of that is necessary to know more details about the market dynamics, products/applications segmentation and main purchase drivers.
As part of its coverage, this report contains the following data:
The survey was performed interviewing Distributors with local or regional presence, opinion leaders, manufacturers of systems and reagents for the Life Sciences market segment, research institutes and tender's calls. Twenty two interviews were performed that let gather information about eight countries (Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru and Uruguay) along the period June/September 2013.
This market survey and analysis shows information about geographical distribution, lab category distribution, manufacturer's analysis, instruments distribution by throughput category and market trends for the coming years. As part of its coverage, applications were not in the scope of this report.